Pediatric pneumonia severity score (PedCAPS)

Derivation and Validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) Score

NIH-funded research Lurie Children's Hospital of Chicago · NIH-11292391

This project will create and check a simple score to predict how serious pneumonia will be in children who come to the emergency room.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLurie Children's Hospital of Chicago NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-11292391 on NIH RePORTER

What this research studies

If your child comes to the emergency department with suspected community-acquired pneumonia, researchers will use clinical information from many hospitals to build a short, practical score to predict which children are likely to become very sick. They will combine routine exam findings with blood biomarkers (like C-reactive protein and procalcitonin) and viral test results to see if these add useful information. The team will develop the score using data from multiple pediatric EDs and then test it in separate hospitals to make sure it works broadly. The work builds on an earlier single-center rule but aims for wider validation so doctors can use the score with more confidence.

Who could benefit from this research

Good fit: Children roughly 3 months to 18 years old who present to a participating emergency department with suspected community-acquired pneumonia are the ideal candidates.

Not a fit: Newborns under about 3 months, adults, cases of hospital-acquired pneumonia, or children with very complex chronic conditions may not be represented and might not benefit from this specific score.

Why it matters

Potential benefit: If successful, the score could help doctors decide who needs hospital care, extra tests, or stronger treatments and who can safely go home.

How similar studies have performed: Adult pneumonia risk scores have improved care, and a prior single-center pediatric rule showed promise, but multicenter validation and the use of added biomarkers is a newer step.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.